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INTRODUCTION

The increased use of carbamates as pesticides during the past
ten years has stimulated the need for toxicologic, pharmacologic, and
environmental pollution studies of these compounds so that toxicity
due to acute and long-term exposure can be rationally treated.

One of

the most critical parameters influencing toxicity is metabolism.

If

a compound is to be administered to man ideally, its excretion, absorp
tion, and metabolism should be studied in man.

However, it is obvious

that compounds toxic to man cannot be screened or tested in man.

The

solution to date has been the detection and utilization of an experi
mental or suitable animal model that closely resembles man in its
handling of the compound of interest.

An added complexity with both

of these methods is that usually each step of a pathway of metabolism
is mediated by a specific enzyme.

Therefore, species and individual

variation will be the rule rather than the exception (Goldstein et al.,
1968).

Usually when animal models are used, several species are

studied to minimize the risk of a particular species giving an idio
syncratic response or result.

No matter how exhaustive animal studies

are, they do not necessarily predict the out-come on ingestion of a
substance by the human subject.

Therefore, comparative human studies

of metabolism should be carried out whenever possible.
Other reasons for the accumulation of this type of data are:
1.

With the rapid development and application of chemicals to
our environment by agriculture, transportation, and
medicine, it is necessary to become aware of the potential
hazards of acute and long-term exposure and their
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synergistic interactions in the animal and in the natural
ecological settings.
2.

Toxicological Aspects: Chlorphenothane (DDT), Chlordane,
and Lindane have been extensively sprayed on food and
livestock in the past twenty years, and the residue
problem of this highly lipid soluble compound is just
now being seriously considered.

There is probably no

food category in the world that is not contaminated to
some degree with a pesticide residue.

What is of critical

importance is the chronic effect from small constantly
increasing amounts of residual pesticides being accumu
lated in the body for twenty to thirty years.

Especially

since it has been found that chlorinated hydrocarbons are
potent microsomal drug metabolizing enzyme inducers.
Induction by halogenated pesticides has been implicated
in the accelerated metabolism of cortisol, estrogens,
androgens, and progesterones (Azarnoff, 1970).

The

accelerated metabolism of reproductive steroids could
decrease the effectiveness of the birth control pill.
Therefore, it is necessary to evaluate the potential health
hazards of carbamates and their metabolites to avoid future toxicological problems that now face us because of DDT.

It has been found

that carbamate pesticides are contact pesticides, with long residual
properties which are highly selective in their pesticidal action.
Generally, the entire group of lipid soluble N-methylcarbamates
represent a selective approach to pest control of ectoparasites of

3
poultry, fruit trees, beans, and cotton (Metcalf, 1965).

The principal

reason for this selective action is due to the various rates and path
ways of in vivo metabolism in the different species.

For example,

N-acetylated Zectran is almost nontoxic to the mouse while being
extremely lethal to the leaf bud worm.
due to metabolism.

The difference in lethality is

The leaf bud worm de-acetylates the N-acetylated

Zectran regenerating Zectran itself.

This is toxic to the insect,

while the mouse detoxifies the carbamate moiety by hydrolyzing it
(Miskus, 1969).
The mechanism of toxic action is closely related to the mode
of action and metabolism of the pesticide.

Factors influencing these

parameters are physical-chemical properties and its degradatory modifi
cation, if any.

Subtle alterations in any of the above parameters may

prolong or prevent the appearance of toxic effects in the animal
(Frazer, 1967).

The increased knowledge of the mechanism of action

and metabolism of a substance in a number of species should help in
the search for new pesticides and the understanding of those now in
use.
The structures of the carbamate pesticides studied in this
investigation are shown in Figure 1.
Literature Review: Mechanism
of Action and Metabolism
The carbamate pesticides act in mammals by inhibiting cholin
ergic structures.

The mechanism of this inhibitory action is dependent

upon carbamylation of the enzymes—acetylcholinesterase and pseudo
cholinesterase—at their active sites resulting in the accumulation of
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Figure 1

Chemical Structures of Zectran and Mesurol

acetylcholine.

The increased presence of acetylcholine (ACH) gives

rise to the typical parasympathetic symptomology of lachrymation,
salivation, myosis, convulsions, fasciculations, weakness, fibrilla
tions and death (Goodman and Gilman, 1965).

The decreased toxicity to

mammals is due to the fact that the above carbamylation of acetyl
cholinesterase (ACHE) is more readily reversible in mammals than in
insects (Metcalf, 1965).

The detailed carbamylation and the phosphory-

lation of ACHE has been one of the most studied enzyme-inhibitor
reactions.
Initial studies with carbamates proposed that the mechanism of
ACHE inhibition was simply a reversible inhibition complex (1) where
E is the enzyme, C the carbamate group [C(0)NR2] and X the remainder of
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E

carbamate molecule.

+

ECX

CX

(1)

Evidence supporting this view was that inhibition

can be reversed by washing (Aldrige, 1953), dialysis (Kolbezen, 1954),
dilution (Goldstein, 1951), or addition of substrate (Goldstein, 1944).
In 1960 Wilson et al. demonstrated with hydroxylamine that the inhibi
tion depended upon C rather than X, suggesting that X leaves in the
reaction.

Recently, O’Brien (1966, 1968), employing tritiated carbaTherefore, the

mates, measured the rate at which X actually leaves.
over-all reaction can now be drawn as follows:

E

+

ECX

C
k-1

k
---*

k3

EC

»

E

+

C

(2)

X

The rates of all the reactions have been calculated for most of the
carbamates.

From equation (2) it can be seen that there are primarily

three steps in the reaction:
1.

Complex formation which is mathematically described by the
affinity constant, K = k
Si

J-

/k-.
_L

Due to the reciprocal

form of the equation, the smaller the K

Si

the higher the

affinity of the substrate for the enzyme.
2.

Carbamylation of the enzyme and the leaving of the ring
moiety.
in K

3.

The rate of this part of the reaction is given

2*

Decarbamylation of the enzyme, or the recovery of the
enzyme, given by the K^.

The proof of the existence of a complex has been taken for
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granted.

Only until recently has it been substantiated.

Verification

of the complex was difficult because at very high substrate concentrations. 10

-4

M, carbamylation is so fast that the reaction is almost

complete within a few minutes.

For example, Mesurol has a Ka= 0.0067

^ (O’Brien, 1968).

and K2= 1.24 minutes

reaction, the half life of K^+

Assuming a first-order

is approximately 0.558 minutes.

Therefore, if one adds 100 umoles of Mesurol to ACHE, carbamylation
is 99.9 percent complete after two minutes.

Techniques have been

developed to slow the reaction to allow an in-depth study of the
kinetics involved.

The

of the reaction is very slow and is the

reason for the manifestation of the toxic syndrome.

Equilibrium

constant three, K^, is equal to a half life of approximately fourteen
minutes.

The slow recovery of the enzyme accounts for the observation

that carbamates appear as inhibitors of ACH rather than extremely good
substrates with very little turnover.

The slow

also creates a

complex steady-state relationship as shown below (O’Brien, 1967).

^H+X
However, because the K

is so fast, one can ignore complex forma

tions, usually, and the essential cycle is as follows:

eoh-a:
k

k2

3

EOA*
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This is not an equilibrium but a steady state because the carbamate
is being progressively destroyed by the ACHE.

The precise point at

which the steady-state will be reached is shown by the following
mathematical relationship:

k3(ec)

=

k2(ecx)

O’Brien (1967) has suggested that when approximately 95 percent is in
the carbamylated form and 5 percent in the reversible form, a steady
state is reached.

Mathematically expressed:

K2

=

20 K3

In summary, the carbamates follow the usual Michaelis-Menton
kinetics.

They are competitive inhibitors of ACHE and because of

their slow rates of decarbamylation as opposed to the fast rate of
complex formation, there results a carbamylated enzyme with a very
slow recovery.

Due to the slow decarbamylation and the affinity of

carbamates for ACHE, a steady-state relationship is established.

The

importance of the enzyme-carbamate interactions is that detoxification
systems produce molecular modifications which result in different
steric and electronic configurations of the molecule that may increase
or decrease toxicity.

The rat produces metabolites from Zectran and

Mesurol that are more potent cholinesterase inhibitors than the parent
compounds (Oonnithan, 1968).

Metcalf and Fukuto (1965) have studied

this in depth.
It had been assumed up until 1963 that the metabolism of
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carbamates was primarily due to hydrolytic pathways.

That is, it was

due to the simple hydrolysis of the carbamate ester by acetylcholin
esterase and pseudocholinesterase.

However, after considerable kinetic

studies were made, it was realized that the carbamates had such a high
K

cl

resulting in a very slow turnover of the ACH that the ACHE enzyme

could not possibly be the major route of detoxification (Casida, 1960).
Human and rat plasma albumin has been shown to hydrolyze Sevin (Casida,
1959), p-nitro phenyl N-alklycarbamate and Baygon and may be of some
significance in the detoxification scheme.

Although highly improbable,

degradation of carbamates may be catalyzed by nonspecific serum pro
teins in the blood associated with the albumin faction.

Casida (1959)

has reported "carbamatase-like" activity toward some carbamates.
O’Brien has calculated the amount of acetylcholine hydrolyzed by acetycholinesterase and found that 300,000 molecules of acetylcholine are
hydrolyzed per minute.

For methylcarbamates the rate was 0.04 moleConsequently, ACHE hydrolyzed carbamates

cules/minute (O'Brien, 1969).

very slowly, thereby effectively tying up the enzyme.

The result is

accumulation of ACH.
Hodgson and Casida (1960) were the first to recognize or
correlate the importance of non-hydrolytic pathways when they observed
that N,N dimethylcarbamates were degraded by an oxidative attack on
the methyl group which yielded a hydroxylated p-nitrophenyl N-methylcarbamate.

The reaction appears to be mediated through the microsomal

mixed oxidase enzyme group.

This was suggested by the need to fortify

the jin vitro rat liver enzyme preparations with reduced nicotinamideadenine dinucleotide phosphate.

This system is associated with the
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smooth endoplasmic reticulum of a number of mammalian cells such as
liver, kidney, and intestine.

The basic pattern of metabolism of this

non-specific system involves the introduction of an atom of molecular
oxygen into the subtrate molecule concomitant with the oxidation of
reduced triphosphopyridine nucleotide.

This reaction usually results in

an increased hydrophilicity of the product.

Gillette (1957) has demon-

strated the various types of reactions catalyzed by this system (See
Figure 2).
The asterisked reactions in Figure 2 account for the major
molecular changes that occur on the carbamate molecule due to the NADPH
system.

The exact mechanism of the hydroxylating intermediates remains

controversial.

The nature and resolution of the suspected critical

intermediate "p-450,f is the center of the controversy.
the p-450 assume in the hydroxylation reaction?

What role does

For the present dis-

cussion the protein p-450 can be considered as being an oxygen trans
ferase; therefore, many of the oxidative reactions may be written as
hydroxylations (Goldstein 1968) as has been done in Figure 2.
The application of a centrifugal force of 15,000 g to a homo
genized animal liver results in a supernatant containing the soluble
fraction and the NADPH oxidase system.

If just the NADPH^ system is

desired, the 15,000 g supernatant can be centrifuged again at 95,000 g
for one hour.

Oonnithan (1968) found that either of the above rat

microsomal preparations incubated with Zectran qualitatively produced
nine ether-extractable metabolites.

The major metabolites produced

were the 4-methylamino-3,5-xylylmethylcarbamate (MA) (42.6 percent),
and N hydroxymethyl (11 percent) derivatives of Zectran implicating

10
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Figure 2

Chemical Reactions Mediated Through
the NADPH Oxidase System
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N-dealkylation and hydroxylation as the major detoxification reactions.
Minor metabolites were 4-methylformamido-3,5-xylyl N-methylcarbamate
(MF) at 1.9 percent and 4-amino-3,5-xylyl N-methylcarbamate (A) at
3.8 percent.

Five metabolites have still not been identified.

The

data indicate that N-dealkylation increased the toxicity of the metabo
lites MA and A since they are more potent acetylcholinesterase inhibi
tors than the parent compound (Oonnithan, 1968).

This may be possible

because MA and A may be more able to form hydrogen bonds than the
alkylated amino group of Zectran.
In vivo studies on Zectran are much more complex and confusing
than in vitro.

Krishna and Casida (1966) injected rats intraperiton-

eally with ten different carbon-14-labeled carbamates including
Zectran.

After forty-eight hours the following distribution of radio-

labeled Zectran was:

C

14

0

67.2%

Urine

Feces

Body

Total

24.2%

2.6%

8.8%

104.4%

Krishna arrived at the generalization that in the rat para-substitutents resulted in a higher proportion of C-14 being eliminated as
C140 2 than those without para-substitutents.

Secondly, he generalized

that Zectran yielded the highest residues persisting in bodily tissues.
Levels of Zectran were highest in the brain, heart, kidney, liver,
lungs, and spleen.

The in vivo work on the rat shows that Zectran is

widely distributed in the body and that decarbamylation, or hydrolytic
removal of the OCONCH^ group is the major detoxification route.

These
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data differ markedly from Oonthian and Casida who found 46.2 percent of
C-14 in the liver being converted to MA.

Therefore, Zectran metabo

lites are probably being hydrolyzed even after leaving the liver,
although no investigation has found 4-methylamino-3,5-xylenol in the
urine.

These data are not consistent with the rate of turnover of

methylcarbamates by the acetylcholinesterase.

Present work in the

Pharmacology laboratory is trying to verify the validity of decarbamylation to the extent reported by Krishna and Casida by in vitro means.
In vivo studies of Zectran have also been done in the dog, although
the studies were done on a chronic basis and confined to the urinary
metabolites.

Williams (1964) found 4-dimethylamino 3,5-xylenol, 1.9

percent free and 86 percent conjugated as the major urinary metabolite.
A minor metabolite identified in the urine was 2,6-dimethylhydroquinone, 5.5 percent.

Identification of dog urine metabolites indicates

little metabolism other than hydrolysis, although no attempt was made
to analyze the possibility of altered functional groups on the phenol.
Since hydrolysis is supposedly the major reaction you would expect to
see a great amount of the phenol, which Williams identified in the
urine.

Two,6 dimethylhydroquinone has not been found in the rat urine.

No in vivo rat experiments have been done on rat urine for Zectran
except that of counting C-14 activity after forty-eight hours.
Even fewer metabolic studies have been done with Mesurol both
in vitro and in vivo than with Zectran.

The only in vitro work

reported in the literature was that done by Oonnithan (1968) who used
15,000 and 95,000 g rat liver supernatants.
extractable metabolites.

He found five ether-

The major metabolite was 4-methylsulfinyl-3,
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5-xylyl N-methylcarbamate (sulfoxide) 5.8 percent.

The other radio-

labeled regions were not identified, except for 4-methylsulfonyl-3,5xylyl N-methylcarbamate (sulfone).
In vivo work is limited to Krishna and Casida (1966) who
studied the fate of various C-14-labeled methylcarbamates in rats.
Again it was found that decarbamylation, 66 percent, was the major
route of elimination with 22.3 percent excreted in the urine and 2.5
percent in the feces.
animal.

Mesurol was also widely distributed in the

It followed the Zectran pattern of residual properties but

there was not as much deposited.
If the compounds are metabolized so rapidly by mammals, why
are carbamates toxic to insects?

The first consideration of suscepti

bility to carbamates is the presence or absence of cholinesterase in
the insect and the differences of insect and mammalian cholinesterase.
Investigations using propionyl, butyryl, benzoyl, and acetyl beta
methylcholines demonstrated that insect enzymes had properties very
similar to mammalian erythrocyte acetylcholinesterase

(Metcalf, 1965).

Despite similarities it was found that the housefly was less able to
metabolize Mesurol, Band, and Baygon by hydrolysis; however, in vitro
fly preparations fortified with NADPH^ will hydroxylate carbamates very
rapidly.

It has been postulated, therefore, that the housefly's path-

way of detoxification is the NADPH^ oxidase system,

Supporting evi-

dence is the effect of piperonyl butoxide, a microsomal enzyme inhibi
tor, of increasing the

of houseflies and its in vitro effect of

decreasing hydroxylation (Metcalf, 1967).
Other studies investigating the in vivo and in vitro effects
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of carbamate pesticides are those of Baron, 1966; Borough, 1964; Borough
et al., 1963; Hassan et al., 1966; Knaak et al., 1968; heeling, 1966.
The object of this research was an in vitro metabolic comparison
of phenyl N-methylcarbamates incubated with liver and blood fractions
obtained from man, rats, and dogs.

Resolution and identification of

metabolites produced should give an indication of the degradative path
ways of toxicological significance.

Because of the need to identify

structural characteristics of Zectran and Mesurol metabolites, attempts
at chemical methods to determine functional groups were studied.
Another means to determine functional groups was the development of gas
chromarographic methods for carbamates and their metabolites.

MATERIALS AND METHODS

Radioactive Materials
The C-14-labeled compounds used in the study were supplied by
New England Nuclear of Boston, Massachusetts.
were labeled in the carbonyl position.

Both Mesurol and Zectran

The radiochemical purity was

greater than 99 percent as determined by thin-layer chromatography on
silica gel G in ether:hexane:ethanol 77:20:3.

Both of the labeled

compounds were adjusted with their respective pure non-labeled compounds
to a specific activity of 1 mc/mM prior to use.
Sodium carbonate labeled in the carbonyl position was purchased
from New England Nuclear.

Its specific activity was adjusted with pure

non-radioactive sodium carbonate to 0.53 mc/mM.

Toluene C-14, used for

spiking and efficiency determinations, was also purchased from New
England Nuclear.

It was standardized and contained 4.25 x 10^ dpm/ml

at 25°C.

Non-labeled Materials
Non-labeled carbamates and their phenols used in the study were:
1.

Band (6-chloro-3,4-dimethylphenyl N-methylcarbamate)

2.

Bayer 37344 (4-methylthio-3,5-dimethylphenyl N-methyl
carbamate)

3.

Bayer 39007 (O-isopropoxyphenol N-methylcarbamate)

4.

Bayer 42696 (3(-dimethylamino)-4-methylphenyl N-methyl
carbamate)

5.

Bayer 50282 (4-(diallylamino)-3,5-dimethylphenyl N-methyl
carbamate)
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6.

Carbaryl (1-naphthyl N-methylcarbamate)

7.

HRS 1422 (3,5-diidopropylphenyl N-methylcarbamate)

8.

HRS 9485 (0(alloxy)phenyl N-methylcarbamate)

9.

Matacil (4-(dimethylamino)-3-methylphenyl N-methylcarbamate)

10.

3-Methylphenyl N-methylcarbamate

11.

Phenyl N-methylcarbamate

12.

Zectran (4-(dimethylamino)-3,5-methylphenyl N-methylcarbamate)

The carbamates were obtained from the following sources:
compound 1 was supplied by Upjohn Company, compounds 2-5 and 10 by
Chemagro Corporation, compound 7 by Hooker Chemical Company, and
compound 8 by Hercules Powder Company; compounds 10 and 11 were synthe
sized by the method of Benson (1966).

The phenol moiety of the carba

mates, when not supplied by the manufacturer, was obtained by hydrolysis
of the respective carbamates.
Absorbent for CO^ traps was Ethylene glycol monomethyl ether
(EGME): monethanolamine 2:1, and both compounds were supplied by the
Fisher Scientific Company.

The scintillation cocktail used for the

liver and kidney incubations utilized either Spectrofluor (New England
Nuclear) or 0.55 percent 2,5-diphenyloxazole (New England Nuclear) in
toluene and EGME 2:1.

Bray's scintillation cocktail (Rapkin, 1963)

was used for counting radioactivity in aqueous systems.
rat and human blood studies

The last two

utilized Bray's dioxane-based system.

Additional components added were 60 g of napthelene, 20 ml ethylene
glycol, 4 g PP0, 200 mg 1,4-bis[2-(5-phenyloxazolyl)]benzene(P0P0P),
100ml methanol and p-dioxane (to make 1 liter).

Materials used in the
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mixture were nicotinamide adenine dinucleotide phosphate

(NADI’), k1ucose-6-phosphate (G-6-P), glucose-6-phosphate dehydrogenase
(G-Ol’D) (all. obtained from Sigma Chemical Company), magnesium chloride
Male Sprague-Dawley rats of 250-350

(Baker), and nicotinamide (Baker).

grams wore purchased from Simonsen Laboratories in Gilroy, California.
Dogs were obtained from the Loma Linda Animal Care Facility,

Human

biopsy samples were obtained from the Department of Surgery, Loma Linda
University Hospital at the time of surgery.
Physical separation of the carbamates and their metabolites
was done on thin-layer chromatography (TLC).

Silica gel G was obtained

from Kensington Scientific for TLC.

Preparation of Homogenates
and Thin-layer Chromatography
Preparative procedures for the actual in vitro incubations
varied with the animal involved.

Sprague-Dawley rats were either

cervically dislocated or placed under light ether anesthesia and the
blood and liver removed.

A vacutube assembly obtained from Becton,

Dickson and Company was used to withdraw blood from the abdominal
aortic artery at the bifurcation of the two femoral arteries.

After

the blood was taken, the liver was removed and immediately placed into
ice-cold 0.25 M sucrose to cool and maintain the liver enzymes at
approximately 0°C.

The liver was cut into small pieces and placed in

a pre-weighed beaker containing 20.0 ml of the sucrose solution.

After

weighing, enough sucrose solution was added to make a 20 percent homogenate.

The suspension was homogenized in a glass-teflon homogenizer

for one minute and centrifuged at 15,000 g for thirty minutes.

The
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supernatant was used as the enzyme source.
Human liver, after removal from the patient, was placed immediately into ice-cold 0.25M sucrose.

Because of the prompt and immediate

cooling and handling of the biopsy specimens, human liver enzyme prepa
rations should be comparable with in vitro rat and dog studies.

The

following changes in procedure were observed with human samples; other
wise they were treated the same as rat livers: human tissue was blotted
on weighing paper due to the paltry size of the samples, and before
homogenation the liver was blended in a blender for twenty-five seconds
because of the increased concentration of connective tissue present in
the human liver.
Liver and kidney specimens from dogs were treated in the same
manner as human liver specimens.

Procurement of the samples was done

by anesthetizing the dog with Nembutal and making a high median abdominal
incision exposing both the liver and the kidney.
To insure that the enzyme systems would operate under optimum
conditions, a NADPH generating system was added to the incubation flasks.
The cofactor cocktail contained nicotinamide adenine dinucleotide
phosphate (NADP) 1 uM; 20 uM G-6-P; 0.5 units G-6-PD; 25 uM magnesium
chloride; 50 uM nicotinamide per flask.
The carbamates were dissolved in benzene solutions.

Either

100 or 200 ul aliquots (1-2 mM) were added to the bottom of the 25 ml
Erlenmeyer flasks and evaporated in air under the hood.

After complete

dryness was achieved, 0.1 ml proplyene glycol was added to solubilize
the carbamates in the incubation mixtures.

Other constituents added

to the flasks were 1.9 ml of cofactor cocktail, 1.0 ml of the 20 percent

19
homogenate making a total volume of 3.0 ml.

A 10 ul sample of the

original carbamate was counted for C-14 activity at the same time the
compounds were added to the flasks to determine the total dpm added to
the flasks.

The flasks were shaken in a Dubnoff metabolic shaker at

37°C for two hours.

After incubation the homogenates were extracted

with ether immediately or frozen.

The homogenates that were frozen

were kept up to maximum of forty-eight hours before extraction.

Prior

to ether extraction, aliquots of 50 ul were withdrawn to determine
C-14 losses during incubation.

Extraction of organo-soluble compounds

was accomplished with 20 ml of ether.

The ether samples were dried

overnight in a refrigerator over Na^SO^ and then filtered through
Whatman No. 1 filter paper into 100 ml round-bottom flasks.

A Gilford

rotary evaporator was used to reduce the ether to a volume of 2-6 ml.
The 2-6 ml of ether was transferred to 15 ml conical centrifuge tubes
and evaporated to dryness under a stream of nitrogen.
usually picked up in 120 ul of absolute ethanol.

The residue was

Samples of 10 ul were

drawn for scintillation counting of the ether phase which was done in
a Beckman LS-250 liquid scintillation spectrometer.

The remainder of

the sample was spotted on 8 x 8 0.25 mm silica gel G TLC plates and
developed in either of the following two solvent systems.
First
Direction
(Shown Vertical)

Second
Direction
(Shown Horizontal)

A

ether:hexane:ethanol
77 : 20 : 3

ether:hexane
80 :
20

B

Chloroform:Aceonitrile
80
20

ether:hexane
80 :
20
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Plates were exposed from three to seven days to Singul-X/AP No Screen
film to locate radioactive areas on them.
Standards were co-chromatographed with the unknowns and visual
ized by means of a chromogenic spray reagent—10 percent NaOH—heated
for five to ten minutes, followed by ninhydrin in 65 percent ethanol
and heated until visualization, usually a pink color.
Radioactive spots which appeared on the X-ray film were appro
priately outlined on the TLC plates.

These spots were removed and

either placed in a scintillation vial for determination of the radio
activity, or radioactive areas with common R^’s were pooled and
extracted with 2 x 8 ml of ether.

The samples extracted with ether

were then evaporated to dryness under a gentle nitrogen stream.

The

residue was picked up in 40 ul of ethanol and chromatographed in the
gaseous phase (GLC) or used in spray reagent tests.

GLC Identification of
Carbamates and Their Metabolites
A method of successful separation of phenyl N-methylcarbamates
in the gaseous phase has been achieved with a 3 percent OV-17 liquid
phase.

Zectran and Mesurol and their metabolites have been chromato

graphed minimizing breakdown to the phenol moieties.

The usefulness

and quality of separation of the OV-17 is seen in the parameters of
percent breakdown, carbamate:phenol ratios, peak symmetry values, and
height equivalent to theoretical plate values.

A separate investi

gation was made to evaluate the above parameters as a function of
temperature for a variety of different carbamates.
columns were used in the study.

Two different

One column contained OV-17 (Applied
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Science Laboratories) and the other was a mixed liquid phase column
containing 1.5 percent SE-30 (non-polar) and 2 percent Carbowax 20 M
(polar).

These columns were studied to determine if the N-methyl-

carbamates could be chromatographed with little loss due to decomposition on the column.

Previous attempts at developing a liquid phase to

accomplish this with such a wide range of pesticides has been unsuc
cessful.
The 3 percent w/w OV-17 (low polar) liquid phase was prepared
on 100/120 mesh Cromosorb AW-DMCS high performance support,

The packing

was placed in a 4 ft. x 5 mm U-shaped glass tube and conditioned
seventy-two hours at 190°C for sixty hours at less than 87 ml nitrogen/
min and then for twelve hours at 87 ml N^/min.
The second column was a mixture of 1.5 percent SE-30 (non
polar) and 2 percent Carbox^ax 20 M (polar) liquid phases on 80/100 mesh
Gas Chrom. Q (Applied Science Laboratories).

It was conditioned at

215°C for twenty-four hours at less than 80 ml N^/min and then for
twelve hours at 84.7 ml N^/min.
The instrument utilized was a Barber-Colman Series 5000 DualColumn Gas Chromatograph, employing flame ionization detectors,

The

detector bath was maintained at 250°C and the injection port at 260°C.
Experimental variables such as percent breakdown, carbamate:
phenol ratio, peak symmetry values, and height equivalent theoretical
plate values were examined as a function of temperature with the flow
rate being held constant,

The flow rate during the experiment through

the OV-17 column was 88 ml N^/min.
column was 100 ml N^/min.

The flow rate through the SE-30
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Equimolar solutions (0.226 M) of all the carbamates were
prepared fresh and the standard injection volume used was 1 ul.

The

calculation of retention times was made from the solvent front to maximum peak height.

A polarity test was performed on both columns by

injecting a mixture of ethanol, methyl ethyl ketone, cyclohexane and
benzene in a 40:20:5:10 volume relationship at 72°C.

Derivatization Techniques
Derivatives made with KMnO^, NaBO^, hydroxylamine, Trimethylsilyl imidazole and bis(trimethylsilyl)trifluoracetamide Regisil (Regis
Chemical Company, Chicago) may be useful in subtractive chromatography.
Functional groups can be tentatively identified by a reaction of a
compound with one of the above reagents.
compound’s peak from the gas chromatogram.

This usually removes the
In the case of carbamates,

Regisil and TMS imidazole decrease the polarity of the molecule and
hence shorten the retention time on the OV-17 column.

NaBO^ is suppos

edly a derivatizing reagent, producing an alcohol from a carbonyl
group; however, the procedure used failed to produce an alcohol peak
after the removal of benzoic acid with NaBO..
4
The parameters to a certain extent have been investigated in
relation to carbamate pesticides.

NaBO. (1) removes benzoic acid—no
4

corresponding alcohol peak; (2) very small reaction with benzaldehyde;
(3) some reaction with Zectran but quite small; (4) no reaction with
Zectran or Mesurol phenols; (5) no reaction with 4-Methyl-formamido-3,
5-xylyl methylcarbamate; (6) removes the 4-formamido-3,5-xylyl methy1carbamate.

In summary, NaBO^ will combine with a ring-substituted

carboxyl group but not with a ring-substituted aldehyde group.

It will
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vlcrlvatls>p tho 4-formamido-3,5-xylyl(F) but does not react with the
**-methyl (vM nwunido-3,5-xylyl methylcarbamate(MF)
llydroxylamine derivatizes F and 4-amino-3,5-xylyl methylcarbacuite but not their methylated analogs.
Roglsil reacts with carboxylic acids, hydroxyls, and amine
functional groups.

Specific reactions with carbamates reveal that

Kegisil does not derivatize Zectran or Mesurol but does form derivatives
with the phenols of each compound.

The 4-amino-3,5-xylyl and 4-methyl-

amino-3,3-xylyl methylcarbamates and their phenols are also derivatizable
with Regisil.

Fractionation of Blood
and Carbon Dioxide Collection
Plasma was separated from red blood cells by centrifugation at
3100 g for fifty minutes.

Typical incubations had red blood cells

resuspended in 0.1 M 7.4 KPO^ buffer in the approximate volume occupied
by plasma.

The carbamate was added as before, in a benzene solution

deposited in the bottom of a 25 Erlenmeyer flask, and evaporated to
dryness.

Solubilization of the carbamate in the aqueous medium was

achieved by adding 0.1 ml of proplyene glycol.
The major in vivo reaction for many carbamates is the hydrolysis
and expiration as carbon dioxide.

Therefore, CO^ collections were made

to assess the quantity of radiolabeled carbon dioxide liberated in vitro.
The mechanics of the incubation apparatus were such that a positive
pressure was maintained through the incubation flask and tygon tubing
connecting the flask with the two CO^ absorption towers,
traps contained 15.0 ml of EGME: monethanolamine 2:1.

Carbon dioxide

Preliminary
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studies with radiolabeled NaCO^ indicated that there was complete
There was no significant

absorption of CO^ in the number one trap.

C-14 activity in the second absorption tower,

Flasks were incubated

for two hours at 37°C in a Dubnoff metabolic shaker.

At the conclusion

of the experiment 2.0 ml samples from each tower were counted to
determine the extent of decarbamylation.

C-14 Binding by Blood
Ether extracted and non-extracted blood samples were analyzed
for the amount of C-14 activity bound in the trichloroacetic acid (TCA)
precipitated fraction, presumably protein bound.
the form of a flow diagram in Figure 3.

The procedure is in

Ether was used in the last

experiment due to the great amount of quenching caused by acetone in
the scintillation mixture.

Chromogenic Sprays
Sprays were made fresh for each test.

For a description of

each spray test, specific method of preparation, and proposed mechanism
of action see the Appendix on pages 70-72.

The results of these

tests, although relative, give some indication of the chemical charac
teristics of ring substituents.
Usually 5-15 ul of the extracted radioactive silica gel G were
spotted on silica gel G or cellulose glass plates.

When a positive

spray test is reported in this thesis, it means that the unknown
reacted differently from the parent compound or other important
standards, and also reacted differently than the control.

The control

was the result of removing a small portion of silica gel from a plate
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Red blood cells
Whole blood
serum

0.35 ml 50% TCA stock
solution

1

1

Supernatant
SN
1
count for C-14
activity

Precipitate

1.0 ml of
TCA rinse

4
Supernatant
SN
2
count for C-14

Precipitate
1.0 ml of
ether or acetone

4

4
Organo-solubles
count for C-14

Precipitate
2 n NaOH
70° water bath
for 45 min.

i
P
Sample solution
for C-14 activity

Figure 3
Flow Diagram of the Procedure Used to Evaluate
the C-14 Activity Bound in the TCA Fraction

26
that had experimental R^’s removed.

Method of Calculation
The method of calculation to yield the percent metabolites for
the quantitative data was as follows.

After spiking to determine the

efficiency of counting, the dpm's of all the metabolites minus the
control were totaled and divided by the number of counts placed at the
origin of the TLC plate to find the percent recovery.

The percent

recovery was then divided into each metabolite to correct for losses
on the TLC plate.

The corrected dpm's of each metabolite were divided

by the dpm's present in the ether phase to determine the percent of
each metabolite in the ether phase.

The percent of each metabolite

in the ether phase was multiplied by the total dpm in the ether extract
to determine the total dpm of each metabolite in the ether phase.

The

total dpm in the ether phase was divided by the total ether and aqueous
counts per minute to give the percent of each metabolite of the total
amount of C-14 recoverable.

The total recoverable C-14 was taken as

the 100 percent value to avoid the variability of the extraction
processes being reflected in the quantitative data presented.

RESULTS AND DISCUSSION

Chromatography of
Carbamates in the Gaseous Phase
A preliminary study was conducted before other metabolic studies
were begun to test the feasibility of using the 3 percent OV-17 and SE30+ Carbowax 20 M column in the identification of carbamate pesticides.
On the basis of the elution characteristics of the polarity
mixture, it is felt that the SE-30 liquid phase was slightly polar since
it eluted ethanol first, then methyl ethyl ketone, but could not separate
cyclohexane from benzene.

The OV-17 column was somewhat more polar than

the SE-30 column and was unable to distinguish methyl ethyl ketone from
cyclohexane.
General separation characteristics of the OV-17 column agreed
with the results of Strother (5) and Fishbein (18).

Longer retention

times were observed with thio derivatives (Mesurol) than with ring Nsubstituted methyl carbamates (Zectran, Matacil).

Thermal instability

seemed to be greater with the non-N-substituted methylcarbamates (Carbaryl, Banol).

The data seem to indicate that there was column substrate

interaction especially at lower temperatures with the 1.5 percent SE-30
and 2 percent Carbowax 20 M column.

Oxygen substitution (39007) seemed

to result in shorter retention times than with the ring N-substituted
methylcarbamates (50282, 42686) or the non-ring N-substituted methyl
carbamates (Carbaryl, Banol).

Lastly, the absence of the methyl group

on the number five position of the ring on Matacil tended to decrease
residence on the OV-17 column when compared to Zectran which has a methyl
at carbon 5 of the ring and is otherwise similar to Matacil.

For the
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retention time of each specific carbamate see Table 1.

Retention times

given in Table 1 are relative to 3-methyl phenyl at each specified
temperature for each column.
The retention times of all carbamates chromatographed on the
SE-30 column were shorter than those of the OV-17 column.
stantiates the polarity experiment previously described.

This sub
The SE-30

column, being somewhat less polar, has less affinity for the carbamate
which is then eluted more quickly and results in a shorter retention
time.
The efficiency of separation by the liquid phases of both
columns is shown in Tables 2 and 3.

On the OV-17 column at 180°C the

percent breakdown varied between 4 and 66 percent with eight of the
twelve compounds showing less than 15 percent breakdown.

A closer

examination of the percentage breakdown values demonstrates the practi
cality of using GLC in the identification of N-methyl phenyl carbamates.
Recovery of the intact carbamate was good in most cases.
chromatographed and 95.2 percent was recovered intact.

HRS 1422 was
Values for

other compounds were 3-methyl phenyl carbamate 96 percent, Zectran
91.4 percent, Matacil 92.3 percent, HRS 9485
91.2 percent.

90.6 percent, and Baygon

On the mixed phase column only two compounds showed less

than 15 percent breakdown at 215°C.

In Table 3 height equivalent

theoretical plate values (HETP) were calculated for each carbamate at
each temperature to gain a picture of the efficiency of the whole
column.

Calculations were based on the method of Ettre (21).

The HETP

values correspond best for similar compounds at 190°C on the OV-17.
Matacil and Zectran are closely related (Zectran having a methyl group

Table 1
Retention Times* of Carbamates on OV-17 and SE-30 and 2% Carbowax 20 M
Columns at Three Different Temperatures
1.5% SE-30 + 2%
Carbowax

OV-17
180°C

190°C

205°C

190°C

205°C

215°C

0.0

0.0

0.0

3.4-xylenol-6-chloro methylcarbamate

BANOL

33.35

24.68

19.66

4-(methylthio)-3,5-xylyl methylcarbamate

MESUROL

44.90

54.78

41.55

0.0

0.0

0.0

O-isopropoxyphenyl N-methy1carbamate

BAYGON

16.30

12.85

10.52

12.87

7.36

7.84

3-(dimethylamino)-p-tolyl methylcarbamate

BAYER 42696

30.12

16.34

26.17

15.91

13.50

13.68

4-(diallylamino)-3,5-xylyl methylcarbamate

BAYER 50282

131.10

57.73

62.75

0.0

0.0

0.0

1-naphthyl methylcarbamate

CARBARYL

63.33

50.24

47.31

0.0

0.0

0.0

3.5-diisopropylphenyl methylcarbamate

HRS 1422

33.13

16.32

18.52

12.87

10.93

11.70

Q-(allyoxy)phenyl-N-methylcarbamate

HRS 9485

30.88

18.63

14.79

6.80

2.66

3.00

4-(dime thylamino)-m-1 oly1 me thy1c arbama te

MATACIL

33.13

24.76

18.66

0.0

13.48

14.92

3-methylphenyl-N-methylcarbamate

5.02

3.05

3.93

5.03

3.26

3.57

phenyl-N-methylcarbamate

8.00

6.90

6.51

6.63

4.67

5.14

* Retention time given in minutes relative to 3-methylphenol.
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Table 2
Percentage Breakdown and Carbamate:Phenol Ratio of
Carbamate at Three Different Temperatures
OV-17
180°C
% break
down
BANOL

SE-30

190°C
C/P

%

205°C
C/P

%

C/P

190°C
%

C/P

205°C
%

215°C

C/P

%

C/P

1.83

57.70

0.73

68.9

0.45

BAYER 37344

35.3
66.1

0.51

90.6

0.07

88.3

0.13

BAYER 39007

13.5

6.42

21.9

3.55

17.7

4.66

26.1

2.83

44.2

1.26

41.2

1.42

10.32

50.6

0.97

63.4

0.58

6.9

0.44

68.8

0.45

36.1

1.77

11.3
66.8

11.91
7.95

56.3
80.0

0.97

74.3

3.60

0.77

88.9

0.34

0.50
19.97

8.2

0.25

8.5

0.15

38.8

HRS 9485

4.8
9.4

16.3

11.27

10.74

23.9

0.63

68.5

7.67

MATACIL

7.7

9.63

50.6

5.14

15.9
21.9

5.32

29.9

3.19

29.9

0.46

40.7
38.2

3-METHYL PHENYL
CARBAMATE

4.0

46.3

8.25

10.8

*

88.9

0.13

22.5

3.44

*

70.8

0.36

55.8

0.79

35.8

1.82

15.0

BAYER 42696
BAYER 50282
GARBARYL
HRS 1422

8.81

24.0

PHENYL CARBAMATE*
ZECTRAN

8.6

10.5

15.1

5.66

18.6

4.37

* The phenol peak was very small and in the solvent front.

2.23
11.5

1.61
12.3
8.15
1.46

5.68

Accurate measurement was not possible.
u>
o

Table 3
Height Equivalent Theoretical Plate Values (HETP)* of Each
Carbamate as a Function of Temperature

OV-17

SE-30

180°C

190°C

205°C

BANOL

7.25

5.91

6.17

BAYER 37344

3.59

4.13

6.65

BAYER 39007

5.31

4.57

4.46

BAYER 42696

6.27

2.70

8.30

BAYER 50282

9.52

2.90

6.68

CARBARYL

8.85

5.88

8.94

HRS 1422

6.23

5.18

4.44

HRS 9485

11.06

5.91

6.37

MATACIL

6.23

5.71

6.47

3-METHYL PHENYL
CARBAMATE

5.11

1.52

4.95

0.46

PHENYL CARBAMATE

2.48

1.79

1.80

0.45

ZECTRAN

7.11

5.59

6.34

190°C

205°C

215°C

0.27

0.31

0.43

0.51

0.26

0.32

0.12

0.03

0.05

0.26

0.48

0.57

0.32

0.15

0.44

0.38

* HETP units are in min/mm/feet.
Calculations based on Ettre (21).
w
i-*
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at position 5 on the ring), and had similar HETP values of 5.71 and
5.91 respectively.

HETP values for unsubstituted N-methylcarbamates

were similar: HRS 9425 = 5.91, Carbaryl 5.88, Banol 5.91.

The latter

data indicate that 190°C is the most efficient temperature for the
column to operate at.
was 205°C.

For the SE-30 the most efficient temperature

The conclusion is based upon the close HETP values of

Matacil 0.48, Zectran 0.44, and Bayer 42696

0.43.

Another column characteristic or parameter of column efficiency
is peak symmetry which provides a measure of the degree to which the
system used limits the realization of good column performance.

A

quantitative picture of the excellent peak symmetry obtained with the
OV-17 column is given in Table 4.

Calculations were made according to

the method of Dal Nogare and Chiu (20).

Seven of the twelve carbamates

had very good peak symmetry with little trailing as indicated by Ag
values of +1.05 or less.

Compounds 3, 7, and 10 had near-perfect

symmetry at 190°C as indicated by an Ag value of 1.00.
the asymmetry value (A )
s

2

The square of

can be used to estimate approximately how the

system in use limits the realization of good column performance,

To

gain knowledge concerning the limiting effects of secondary absorption
and instrumental precision by the OV-17 for efficient chromatography
2
of each carbamate, (Ag) values were calculated and specific values for
each carbamate are listed in Table 4.
has an A.g

2

For example, at 205°C Zectran

=1.02, which indicates that the OV-17 is 2 percent less

efficient than should be.
varied from +1.18 to +4.42.

Asymmetry values with the SE-30 column
Marked trailing of peaks on the SE-30

column was observed as exemplified by HRS 9485 with an Ag value of

Table 4
Peak Asymmetry (A ) and Peak Asymmetry Values* Squared (A )
s
s
for Each Carbamate as a Function of Temperature
OV-17
180°C
A

s

A

SE-30

190°C
2
s

A

s

A

2

205°C
2

s

A

s

A

2
s

190°C
A

s

A

205°C
2
s

A

s

A

215°C
2

A

s

s

A

2
s

BANOL

1.08

1.17

1.06

1.12

1.13

1.28

0

0

0

BAYER 37344

1.07

1.15

1.20

1.40

1.25

1.56

0

0

0

BAYER 39007

1.31

1.72

1.00

1.00

-1.05

1.10

BAYER 42696

1.02

1.04

1.13

1.28

1.02

1.04

1.18

BAYER 50282

1.02

1.04

1.02

1.04

1.11

1.23

0

0

0

GARBARYL

1.14

1.30

1.23

1.51

1.05

1.10

0

0

0

HRS 1422

1.01

1.02

1.00

1.00

1.40

1.96

1.46

2.13

1.63

2.66

1.48

2.19

HRS 9485

1.01

1.02

1.07

1.15

1.17

1.37

1.61

2.59

2.78

7.73

4.42

19.54

MATACIL

1.03

1.06

1.14

1.30

1.04

1.08

1.19

1.42

1.32

1.74

1.43

2.05

3-METHYL PHENYL
CARBAMATE

1.03

1.06

1.00

1.00

-1.15

1.32

1.43

2.05

1.55

2.40

1.20

1.44

1.10

1.21

1.10

1.21

1.25

1.56

1.14

1.30

1.43

1.30

1.25

1.56

PHENYL CARBAMATE
ZECTRAN

1.03

1.06

1.15

1.32

1.01

1.02

1.39

1.45

2.10

1.24

1.54

1.45

2.10

1.23

1.52

* Calculations are based on Dal Nogare and Chiu (20).
u>
w
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Table 5
Retention Times of Various Carbamates and Their Metabolic
Products on OV-17 at Various Temperatures
Compound

Temperature

Zectran

190°C

Tr(min)

11.7

4-dimethylamino-3,5-xylenol

190°C

1.58

4-methylformamido-3,5-xylyl methylcarbamate

190°C

9.94

4-formamido-3,5-xylyl methylcarbamate

190°C

13.98

4-methylamino-3,5-xylyl methylcarbamate

190°C

18.80

4-amino-3,5-xylyl methylcarbamate

190°C

20.0

Mesurol

22.5

4-methyIsulfinyl-3,5-xylyl
N-methylcarbamate

190°C

4-methyIsulfony1-3,5-xylyl
N-methylcarbamate

190°C

4-methylthio-3,5-xylenol

190°C

21.6
26.1

Carbaryl

3.5
30.4

4-hydroxy-1-naph thy1 me thy1carb ama t e

180°C

5-hydroxy-l-naphthyl methylcarbamate

180°C

1-naphthol

180°C

3.80
24.2
4.71

The concentration of all solutions was 5 mg/ml. The standard
injection volume was 1 ul. The detector temperature was 260°C, injec
tion port temperature 250°C and the flow rate 88 ml N^/min.
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Trailing may possibly be due to the higher polarity of the

+4.42.

Carbowax 20 M liquid phase.
Gas chromatography of radioactive regions of the silica gel
yielded another verification of the structure of the metabolites.

In

cases of close migration of metabolites, a refined or more sensitive
method of identification was needed.

GLC worked well in that capacity.

The metabolites of Zectran and Mesurol can all be separated
from a mixture with very little decomposition.

Table 5 gives the

retention times of Carbaryl, Zectran, and Mesurol and their metabolite
standards injected onto the column.

Silica Gel Impurities
Physical separation of the carbamates and their metabolites was
done by TLC.

A special problem encountered by using silica gel were

the contaminants that were simultaneously extracted with the compound
of interest.
control.

At times as many as seventeen peaks appeared in the

At the sensitivities demanded to detect metabolites, the

silica gel impurities were a tremendous interfering element and handicap.

The nature of these contaminants has been explored to some degree

as observed in the literature.

Miller and Kirchner (1954) could elute

50-100 mg of a yellow oil substance from 50 g of silica gel G with
acetone or ethyl acetate.

In the studies reported here a yellow oily

residue was eluted from 1 g of silica gel G.

Spitz (1969) and Ma (1966)

performed infrared and N.M.R. analyses on the yellow oily residue they
were able to elute, and found evidence that supports the concept of a
long-chained hydrocarbon which could possibly be coming from the plastic
container.
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Several processes were tried to reduce the level of impurities
when injected into the gas chromatograph.

Redistilling the solvent

before use, Brown and Benjamin (1964) successfully pre-washed plates
with diethyl ether:methanol 20:80 to remove impurities.

Unfortunately,

this technique did not remove the impurities to the level needed.
Another process used by Matthews (1962) was the extraction of silica
gel with boiling methanol before it was spread onto the glass plates
and activated.
The methods outlined above removed most of the impurities.
boiling methanol being the most successful.

If one subjected the pre

washed or methanol-treated silica gel to the logistics of the experi
mental procedure, some of the impurities reappeared.

Spitz (1969)

suggested that some of these contaminants were picked up from the air
while the silica gel was drying after preparation of the plates.

Metabolism of Zectran
Metabolic activity, based upon the amount of unchanged Zectran
recovered from TLC plates, could not be exactly duplicated in each
experiment because there is no method of standardization.

This has

led to some of the variability seen in the quantitative results.
Variability was also observed in the enzyme activity of the different
species investigated.

The degree of enzyme activity was greatest in

the dog, with the rat second and the human last.

Qualitative and

quantitative radioautographic studies with radiolabeled Zectran
demonstrated that the same major metabolic pathways are utilized by all
three species.

Human liver incubations, although not metabolizing as

much Zectran as the rat, produced a small array of metabolites not
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produced in the rat or dog.

Figures 4-6 indicate that the major quali-

tative differences are located between radioactive area 1 and the
unmetabolized Zectran.

In the dog radiolabeled areas h, p, m, and n

either do not occur or are not present in measurable amounts.

Chromo-

genie sprays were used to distinguish any oxidative reactions occurring
on the ring methyl groups.

Two,4-dinitrophenylhydrazine, p-phenyl-

enediamine, bromophenol blue and KMnO^ were used to detect the presence
of aldehydes or organic acids.

Bromophenol blue and KMnO^ reacted at

times with the control, or color development was not distinct enough
for an affirmative test.

P-phenylenediamine did not react with the

metabolites g, m, n, and o.

Gas chromatography of these spots was

done, but due to the extremely small percentages present and the level
of silica gel impurities encountered, no conclusions could be made.
Co-chromatography in both solvent systems A and B made possible
the identification of 4-methylamino-3,5-xylyl N-methylcarbamate (MA),
4-amino-3,5-xylyl N-methylcarbamate (A), 4-methyIformamido-3,5-xylyl
N-methylcarbamate (MF) and 4-formamido-3,5-xylyl N-methylcarbamate
from the incubation mixtures of all three species.

The validity of

thin-layer chromatographic separation was reconfirmed by identification
of these compounds in the gaseous phase.

Representative chromatograms

of MA, A, and MF are shown in Figures 7, 8, and 9.

The TLC work done

with solvent system B agrees qualitatively with the work of Oonnithan
(1968) done with the rat liver.

The only differences in the rat data

presented here and Oonnithan's are the appearance of two minor metabolites .

These differences are insignificant since both of these metabo

lites (h and m) appear in quantities less than one percent.

It was
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Figure 4
Thin-Layer Chromatographic Distribution of Metabolites from Incubation
of C-14 Carbonyl-Labeled Zectran with Human Liver Fractions
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Thin-Layer Chromatographic Distribution of Metabolites from Incubation
of C-14 Carbonyl-Labeled Zectran with Dog Liver Fractions
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Thin-Layer Chromatographic Distribution of Metabolites from Incubation
of C-14 Carbonyl-Labeled Zectran with Rat Liver Fractions
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2i3 min.
Figure 7.

Gas chromatography of 4-methylamino-3,5-xylyl
N-methy1carbamate on 3% OV-17 at 190°. Nonidentified peaks are silica gel impurities.

T

18.8 min.
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Figure 8.

Gas chromatography of 4-amino-3,5-xylyl
N—methylcarbamate on 3% OV—17 at 190 .
Non-identified peaks are silica gel impurities.
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Figure 9. Gas chromatography of 4-methylformamido-3,5-xylyl N-methylcarbamate on 3% OV-17 at 190°. Non-identified peaks are silica gel
impurities.
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found that a more reliable and consistent separation of Zectran metabo
lites in solvent system A yielded more radiolabeled spots than solvent
system B.
Functional group analysis by means of spray reagents was carried
out on metabolites common to all three species, but these were not
identified by co-chromatography with standards, in particular metabolites b, c, s, and 1.

Table 6 summarizes the results of the spray

reagent tests.

Table 6
Functional Group Spray Analysis
of Metabolites b, c, s, and 1

P-dimethyl- Phospho- Bromo- Phloro- Hydrazine
aminobenmolybdic phenol glucin- sulfate
aldehyde*** acid
blue
ol
O

SDL
DK
RL
b
DL
RL
1
DL
RL
HL
c
RL
DL

Bromo- P-phenylcresol enediamine
sum

**

NR*
PINK
NR

NR

NR

NR

NR

NR

NR

YELLOW
YELLOW

BLUE

NR
NR

NR

NR

BLUE

NR
NR

NR

YELLOW
YELLOW

*
**

NR

NR

NR

NR
NR
NR

NR

NR
NR

NR
NR
NR

NR = no reaction
DL = radioactive region from dog liver incubation
HL = radioactive region from human liver incubation
RL = radioactive region from rat liver incubation
*** For preparation and functional group specifics see Appendix
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The picture that arises from Table 6 is that metabolite b may
possibly be hydroxylated or de-alkylated, or both.

Regisil, a deriva-

tizing reagent, has removed a peak in GLC using radioactive area b from
dog liver incubations.

For reaction specifities of Regisil see Methods.

The slight reaction of Zectran with Regisil indicates that the derivatization of area b was probably not a reaction with a 3° amine but most
likely 1° or 2° amine.

The reaction with phosphomolybdic acid suggests

a 1° amine rather than a 2° amine.

The methyl groups at the 3 and 5

positions of metabolite b appear to be intact since neither aldehylic
or carboxylic spray reagents react with it.

The consistent and reliable

reaction of metabolite b with p-dimethylaminobenzaldehyde indicates
again that it may be dealkylated to a 1° or 2° amine with some other
modification of the ring substituents, possibly hydroxylation.
Metabolite s does not seem to be characterized by sprays or
derivatives indicative of N-dealkylation, hydroxylation, or oxidation.
The generalization is supported by the non-reactivity of a wide variety
of spray tests.

Since N-dealkylation is the major reaction with

Zectran, there is the possibility of N-oxidation of the para substituted
amine.

This is only speculation because metabolite s’s characterization

at the most likely possibilities of metabolism was unsuccessful.

N-

oxidation has been shown to occur with the oxidative conversion of
trimethylamine (Baker, 1962).
It appears that radioactive area c is probably more than one
compound.

In several TLC plates the radioactive area is separated

into two areas.

Reaction with p-dimethylaminobenzaldehyde suggests

dealkylation of the para substituted amine to a 1° or 2° amine.
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Oonnithan (1968) has tentatively characterized a radioactive
area as 4-dimethylamino-3,5-xylyl N-hydroxymethylcarbamate (NOHME).
He used TLC and solvent system B.

Supportive evidence in this study

to demonstrate that radioactive region, 1, is hydroxylated was attempted
by using TLC, functional group sprays, derivatives, and radioautography.
If one removes spot 1 and rechromatographs in solvent systems A or B
and then develops a radioautogram, one major radioactive spot (83.4
percent) and two minor ones are observed.

Spraying to visualize the

nonradioactive spots indicates the presence of a small amount of phenol.
Radioautography demonstrates that the carbamate bond is intact.
on OV-17 breaks down the NOHME completely to the phenol.

GLC

Derivatization

with Regisil followed by chromatography yielded a peak that has the
same retention time as derivatized 4-dimethy1-3,5-xyenol.

This

indicated that there is no change on the ring structure.

The only

other possibility left is the carbamate moiety has been altered to
cause area 1 to migrate with the R^ observed,

The most logical place

of attack is on the methyl group attached to the nitrogen of the
carbamate side-chain.

The positive test with phosphomolybdic acid is

another indicator of a hydroxyl group located on the molecule.
The quantitative data are summarized in Table 7.
summary the major route of metabolism in vitro
of N-dealkylation, resulting in MA.

In the

for Zectran is that

Human and dog livers converted

43 percent and the rat 50 percent of the recoverable C-14 to MA.
Complete dealkylation resulting in A, was much less prevalent with
the human who produced 2.6 percent, while the dog produced 7.5 percent
and the rat 9.5 percent of the C-14 recoverable.

Further metabolism

Table 7
Summary of Quantitative Zectran
Metabolism Studies*

ID

a
lb
b
s
c
f
i - MF
j “ A

g
h
k - MA
1 - NOHME
P
m
n
o
z - Zectran

AQ

Dog Liver

0.32
0.67
1.08
5.38
10.95
1.15
1.97
7.93
5.54

Dog Kidney

0.06

Rat Liver

0.35
3.51

89.23

5.05

0.28
0.97
0.61
1.69
0.84
0.41
1.33
2.57
1.73
1.28
43.77
0.58
0.30
0.31
0.52
0.33
31.52

12.64

3.63

9.11

8.67

43.36
8.54

1.35
0.48
0.96
0.65

0.47
0.29
0.16
0.24

0.47
0.64
1.47
1.61
0.57
0.50
6.30
9.51

Human Liver

51.08
9.75
0.25

* Values represent percent of the recoverable C-14 found in metabolites
listed in the left hand column.
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was from an oxidative attack upon the remaining methyl groups of the
para-substituted amine.

MF formation is a minor pathway in the human

1.3 percent and the dog 2.0 percent while the rat produced 6.3 percent.
One of the sharpest differences among the species is the involvement of
the NADPH oxidase system.

Human liver jLn vitro produced only 0.58

percent of the NOHME suggesting the inability of the microsomes to
hydroxylate Zectran, while in the dog 8.5 percent and rat 9.8 percent
NOHME is produced.

Other work in Strother’s laboratory has found the

same trend in comparative
Carbaryl.

vitro studies with Matacil, Band, and

There is one exception and that is Mesurol, a sulfur-

substituted methylcarbamate.
Metabolism of Mesurol
The variability in metabolic activity observed with Zectran was
again observed with Mesurol, but with the rat being the most active in
metabolizing Mesurol, the dog second and the human last.

The qualita

tive picture is one of fewer total ether-soluble metabolites with six
to eight times as much of the C-14 activity passing into the aqueous
phase during extraction.

Extraction and chromatography of the aqueous

phase yields two radioactive spots in solvent system B.

The larger

one had an

similar to 4-methylsulfinyl-3,5-xylyl methylcarbamate

(sulfoxide).

The other radioactive area remained at the origin of the

TLC plate.

Ether extracts of the incubation mixtures contained six

metabolites in human studies, five in the dog, and four in the rat.
The major pathways of Mesurol metabolism in vitro were elucidated by
means of co-chromatography.

The major ether-extractable metabolite

was identified as the sulfoxide.

The sulfoxide was also verified by
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GLC.

A representative chromatogram is given in Figure 10.

The second

has been tentatively characterized as 4-methylthio-3,5-xylyl N-hydroxymethylcarbamate (NOHME).
and B.

Both were identifiable in solvent systems A

This agrees with the data reported by Oonnithan (1968).

He

shows a radioactive area in his chromatograms which has similar chrom
atographic behavior to the tentatively characterized NOHME.

The major

difference is that Oonnithan (1968) found 4-methylsulfonyl-3,5-xylyl
methylcarbamate (sulfone) regularly in the rat (but less than one
percent); whereas, it has not been detected in these studies.
The major distribution of radiolabeled compounds on TLC was
approximately the same for all three species.

Again, the differences

occurred principally in minor metabolic pathways.

It was found (see

Figures 11, 12, 13) that the human produced three metabolites not
present in the dog (g, h, k), and two not found in the rat (g and h).
Lastly, two metabolites are produced in the rat that are not produced
in the dog or human (e and 1).

Functional group spray tests done on

these minor metabolites indicate that oxidation occurs on the ring
methyls.

Metabolite 2A turns yellow upon being sprayed with bromo-

cresol green, a carboxylic functional group indicator.

A positive

test was also observed with p-phenylenediamine, an aldehydic functional
group indicator,

although there was no reaction with hydroxylamine.

These tests indicate an oxidative attack upon ring methyl groups;
however, the extent of oxidation cannot be ascertained with the methods
available at this time.
Metabolite f has been tentatively identified as the 4-methylthio-3,5-xylyl N-hydroxymethylcarbamate (NOHME).

Circumstantial proof
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(SULFOXIDE)

OC(0)NHCH3

\

t
21.6 min.

Figure 10.

Gas chromatography of 4-methylsulfinyl-3,5-xylyl
N-methyIcarbamate on 3% 0V-17 at 190 . Nonidentified peaks are silica gel impurities.
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MESUROL

0C(0)NHCH3

0C(0)NHCH3

oc(o)nhch2oh

a

Figure 11
Thin-Layer Chromatographic Distribution of Metabolites from Incubation
of C-14 Carbonyl-Labeled Mesurol with Human Liver Fractions
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mesurol

0C(0)NHCH3

OC(0)NHCH->o

oc(o)nhch2oh

a

Figure 12
Thin-Layer Chromatographic Distribution of Metabolites from Incubation
of C-14 Carbonyl-Labeled Mesurol with Dog Liver Fractions
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oc(o)nhch2oh
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Figure 13
Thin-Layer Chromatographic Distribution of Metabolites from Incubation
of C-14 Carbonyl-Labeled Mesurol with Rat Liver Fractions
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of its structure was established analogous to the procedures in charac
terizing the NOHME from Zectran.
f

Rechromatography of radioactive area

yielded two spots: one chromatographed very close to the phenol

and the other was a radioactive area midway from the top.
systems A and B were used.

Both solvent

Derivatization of it with IMS imidazole and

Regisil for GLC yielded new peaks on the gas chromatogram,

The

derivative peaks had the same retention times as derivatized 4-methylthio-3,5-xyenol.

Injections of non-derivatized f migrated or had the

same retention time as the non-treated phenol indicating that f breaks
down when being chromatographed on OV-17 or SE-30+Carbowax 20M.

Lastly,

radioautographs show that the f is radioactive, ruling out the possibil
ity that the phenol migrates to the same R^ as the NOHME.

Spray tests

indicate that no alteration of the ring methyls or para-substitutents
has occurred.
The quantitative data for Mesurol are summarized in Table 8.
From the table it can be seen that the formation of water-soluble
metabolites is the major route of metabolism.
able metabolites are the sulfoxide.

The major ether-extract-

The human produces 15 percent,

the dog 16 percent, and the rat 24 percent.

The second major metabolite

has been tentatively characterized as the NOHME of Mesurol with the
human producing 9 percent, the dog 2.5 percent, and the rat 8 percent.
All other metabolites occurred in concentrations of less than one
percent of the recoverable dose.

Again, with Mesurol the greatest

difference appears to be the participation of the TPNH oxidase system
in catalyzing the hydroxylation of the pesticides.

The human liver

catalyzes a great deal of the Mesurol to the NOHME, whereas Zectran

Table 8
Summary of Quantitative Mesurol
Metabolism Studies*

ID

Dog Liver

Dog Kidney

Rat Liver

a
2a
c
q
d
b - sulfoxide
e
f - NOHME
8
1
m
n
h
i
j
k
3 - Mesurol

0.12
0.51
0.19
0.04

0.15

0.10

16.79

2.44

AQ

Human Liver

8.15

88.97

1.9

0.23
0.85
0.16
0.35
0.28
14.97
0.32
9.27
0.47
0.27
0.39
0.51
0.24
0.18
0.08
0.09
26.26

77.14

6.59

57.7

53.73

0.30

2.54
0.21

0.30
26.0
0.26
9.5
0.25
0.41

* Values represent percent of the recoverable C-14 found in metabolites
listed in the left hand column.
Ul
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did not.

Strother (1969, 1970) found that Banol, Matacil, and Carbaryl

follow the pattern of Zectran in that the human produces only trace
amounts (less than one percent) of the NOHME.

Although it is well

established and supported that minor changes in drug molecules can have
a tremendous effect upon metabolism, this is not an explanation for
the phenomena itself.

One possible explanation of why Mesurol is an

exception to the above generalization is that in Figure 14 the P-450
moiety might possess a certain sterospecificity in the human and rat
and that it is not possessed by the dog.

The sulfur on the ring could

approximate a "better" fit than the nitrogen and non-nitrogen-substi
tuted carbamates, and consequently produce more NOHME in the human.
Spectral studies by Gillette (1969) and Estabrook (1969) tend to
support the idea that a certain structural specificity is contained in
the P-450 molecule.
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Figure 14
The Proposed Relationship Between Microsomal Electron Transfer
Reactions Occurring During Drug Metabolism
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In Vivo Metabolism of
C-14 Zectran in the Rat
Correlation of the in vitro data with the in vivo situation is
not possible at this time because of the discontinuities between decarbamylation and jin vitro metabolism.

In vivo the major mechanism of

detoxification is hydrolysis, while this is not the case in vitro.

To

determine the actual amount of in vivo hydrolysis of Zectran, a male
Sprague-Dawley rat was injected with 4.5 uM/kg intraperitoneally with
radiolabeled Zectran and placed in a metabolism chamber for twentyfour hours.

Carbon dioxide was collected and sampled hourly for the

first three hours.

After three hours 47 percent of the administered

radiolabeled dose had been exhaled as carbon dioxide.

After twenty-

four hours 7.4 percent of the radioactivity was counted in the urine.
These results correlate well with those of Krishna and Casida (1966).
Such results are possible in connection with Mesurol, as indicated in
the Introduction of the paper.

Therefore, if in vitro data can be

projected to the understanding of the in vivo situation, Zectran,
Mesurol, and their metabolites are also substrates for ACHE.
cation of this possibility is given by Oonnithan (1968).

Verifi

He found in

ACHE inhibition tests that MA and A are more potent esterase inhibitors
than the parent compound Zectran.

Teleologically it would appear

unacceptable for survival of an individual of a species to produce more
toxic metabolites.

Apparently hydrolysis is so fast that there is no

selective advantage against the toxicity of the metabolites.
Blood Data
Plasma, red blood cells, and whole blood were analyzed for their
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ability to metabolize and hydrolyze carbamates.

Unknown C-14 losses

for the blood samples are quite variable, and this is with no apparent
explanation.

Possible sources of error are: (1) sampling techniques;

and (2) whether the carbamate bond is in fact hydrolyzed, but the
carbamate moiety is immediately bound and not given off as CO^—these
facts are not known.

Carbon dioxide collections reveal that less than

one percent leaves the flask as CO^, yet losses of Zectran from incuba
tions using whole blood range from 16 percent and 32 percent with red
blood cells.

Whole blood incubated with Mesurol lost 90 percent of

the dpm's added to the flask.

C-14 losses with serum range from 0

percent with Zectran to 27 percent with Mesurol.
Despite the difficulties of extracting the blood with organic
solvents, losses due to extraction were minimal with Zectran—0-6
percent—while losses with Mesurol ranged from 0-23 percent.
The distribution of radioactivity after ether extraction pre
sents some interesting problems.

Whole blood incubated i^ith Zectran

for two hours at 37°C when extracted with ether yields a mean of 18.6
percent (N=4) C-14 in the aqueous phase, the controls containing 4-5
percent.

Incubation of Zectran with serum results in 68.3 percent

(N=4) of the C-14 passing into the aqueous phase.

Mesurol follows the

same pattern—90.5 percent of the C-14 found in the aqueous phase of
the incubated whole blood, while 99.5 percent of the C-14 is counted
in the aqueous phase of the serum.
opposite results.

It seems one might expect the

That is, red blood cells plus serum would bind more

than just serum alone.

The possibility that the red blood cell is

interfering with the carbamate binding to the serum is intriguing.
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Some supportive evidence of the interference of binding with serum
protein is that when whole blood is incubated and then centrifuged to
separate plasma and red blood cells, 20-A0 percent more radioactivity
will remain with the red blood cell fraction.
principle with Oonnithan and Casida (1968).

These results agree in
These investigators found

3.77 uM/kg of fresh tissue based on total C-14 of rat blood associated
with the red blood cell fraction, and only 0.44 uM/kg of fresh tissue
based on total C-14 with plasma.

The data suggest that the red blood

cells are interfering at the level of the tightly-held or bound C-14,
P fraction in the TCA treatment (See Figure 3).

Protein binding experi

ments with Zectran and Mesurol rat serum showed that 64 percent of the
C-14 was released upon NaOH digestion.

With the addition of trichloro

acetic acid, 13 percent of the C-14 was released.

However, whole blood

that has been incubated and then centrifuged, releases only 7.2 percent
of the C-14 after NaOH treatment and 80 percent with the TCA.

These

results indicate that when the red blood cell is present, the amount
of C-14 passing into the aqueous phase is reduced and the radioactivity
that does enter the aqueous phase is bound more superficially to the
protein.

A closer look at the protein binding studies showed that

85.6 percent (N=4) of the radioactivity in the serum fraction was due
to protein binding.

With red blood cells the amount of protein binding

was 54 percent of the C-14 in the aqueous phase.

Each step in the TCA

treatment appeared to liberate a consistent amount of the recoverable
C-14.

A flow sheet of the TCA treatment is given in Figure 2 in the

Methods section.

After 0.35 ml of 50 percent stock TCA was added to the

incubation flask, 80 percent (N=4) of the recoverable radioactivity in
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the serum was counted in the SN^+2 fracti°n or TCA supernatant and
54.3 percent with the red blood cells.

Extraction of the sediment with

acetone yielded 15.5 percent (N=2) or ether 5 percent (N=2) of the
recoverable C-14 with serum.
C-14 was extracted with ether.

Whole blood 7 percent of the recoverable
NaOH digestion liberated nearly the

same amount of radioactivity each time, 7.2 percent (N=7).

Within

experiments where the same animal1s blood was used in different flasks,
the percent C-14 associated with the

, A and P fractions was very

close—within 1-2 percent—whereas, inter-animal experiments usually
showed variations of from 3-10 percent.

The observation that a con

stant percentage of C-14 binding suggests the saturation of the serum
protein or a reaction with a specific element in the blood.
Radioactivity lost during the binding studies varied with the
blood fraction.

Zectran serum averaged 13 percent (N=9) loss, Zectran

red blood cells lost 46 percent (N=5) and Mesurol serum averaged 2 per
cent (N=3) losses.
P.

The greatest amount of error arises in steps A and

In step A, where acetone is used to extract organo-solubles, the

color is a dense dark brown which is counted in acetone.
dropped as low as 8 percent.

Efficiencies

Using Bray’s cocktail and extracting with

ether, the efficiency increases to 76 percent.

Step P, which is

the NaOH digestion, has the same dark brown color with some particulate
matter.

Despite this, efficiencies were 61 percent in toluene (N=4),

and in Bray’s cocktail it increased to 91 percent.
Metabolic activity was measured in the rat and dog whole blood
and serum.

It was found that the rat had slightly more N-dealkylating

power than the dog.

The rat produced 6.3 percent and the dog 4.0
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percent of MA in the recoverable radioactivity.

Another metabolite

produced by whole blood was a small amount of MF.

When just the serum

was incubated, there was no metabolism of Zectran.

When just the red

blood cells were incubated, 8.0 percent of the recoverable dose was
converted to MA.
cell—2.6 percent.

MF was produced in more quantity x^ith the red blood
Other supporting evidence that the blood does have

some N-dealkylating powers is provided by Hassan (1966).

He reported

that N-dealkylation can occur with 1-naphthyl methylcarbamate.
Surprisingly very little CO^ was given off by the blood in vitro.
Hydrolysis is the major in vivo reaction.

Values obtained by CO^

collection reveal that more CO^ is liberated by the liver during incubation than by the blood,

In the liver 1.5 percent of the administered

dose is given off as CO^.

The values for whole blood are less than one

percent.

The most CO^ collected was 1.9 percent obtained from Zectran

incubated with serum.

Why blood jin vitro does not hydrolyze more of

the carbamate is hard to understand, unless the carbamate moiety is,
in fact, hydrolyzed, but the Carbonyl-labeled portion is immediately
bound to some unknown fraction in the blood.

Some evidence which

possibly suggests the forgoing idea is observed in that the Mesurol
control CO^ absorption tower traps approximately 2,000 counts per
minute while experimental flasks containing blood in their absorption
towers absorb 800 counts per minute.

The control flasks contain no

protein, whereas the experimental flasks do.
There appeared to be no metabolic activity in the blood toward
Mesurol, since the TLC plates for whole blood showed only unmetabolized
Mesurol.
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Conclusions
In vitro the liver enzymes, especially those associated with the
NADPH microsomal system, are active in metabolizing Zectran and Mesurol.
These enzymes utilize non-hydrolytic pathways in the processes of
degradation.

Oonnithan and Casida (1968) and Borough et al. (1963)

found this to be the case with N-methylcarbamates in the rat.

This

study found that non-hydrolytic enzymes are important in metabolism of
Zectran and Mesurol in the human and in the dog.
The major non-hydrolytic metabolic pathways for Zectran and
Mesurol are shown in Figures 15 and 16.
The pathways of metabolism in vitro for Zectran and Mesurol
cannot be considered mechanisms for detoxification.

Major metabolites

MA and sulfoxide are more potent ACHE inhibitors than Zectran or
Mesurol.

The key to detoxification for carbamate pesticides in mammals

is the hydrolysis of the carbamate moiety.

Most in vitro reactions

involving Zectran or Mesurol do not alter the carbamate moiety.

One

exception is the hydroxylation of the N-methyl group on the carbamate
group.

This reaction may have some toxicological significance because

the NOHME of most carbamates are unstable and will break down to their
respective phenols and CO

2*

It appears that hydroxylation of the

carbamate group would not be important in the human liver since its
reaction occurs with difficulty; whereas in the rat and dog the reaction
occurs more easily.
The red blood cell and the whole blood have little hydrolytic
activity in vitro.

The serum has some "carbamatase” activity.

The

N-dealkylation of the red blood cell and the whole blood are 20 percent,
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approximately, of the amount produced by the liver.

There was no

N-dealkylating activity associated with the serum fraction.
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Major Non-hydrolytic In Vitro Metabolic
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Figure 16
Major Non-hydrolytic in Vitro Metabolic
Pathways for Mesurol
Summary
After considering data obtained from liver, blood, and kidney,
the major site of carbamate metabolism appears to be the liver.

Oxida

tive enzymes mediated by the TPNH oxidase system are the major partici
pants in Zectran and Mesurol metabolism.
The oxidative attack is mainly a para-directed attack on the
molecule.

Mesurol seems to be more susceptible to oxidation of its

ring methyl groups than Zectran, in light of data obtained in this
study.

The major pathway of Zectran metabolism is N-dealkylation in

all three species.

Hydroxylation of the N-methylcarbamate side-chain

occurs to a greater extent in the rat and dog than in the human.

A

minor pathway in all three species is the oxidation of the substituted
methyl groups to formamido and methylformamido derivatives.
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Sulfoxidation is the major reaction observed with Mesurol.
Hydroxylation of the N-methyl moiety is the second most important
reaction in all three species.

The human liver, although not possessing

as much metabolic activity as the rat or dog, in general produced a
small array of compounds not detectable in the rat or dog from both
Zectran and Mesurol.
Blood possessed some N-dealkylating properties and no sulfoxi
dation properties.

Over-all, its metabolic activity was quite low.

Little CO^ was given off in vitro, contrary to the in vivo situation.
Kidney possessed even less metabolic activity toward the carba
mates studied than did the blood in relation to sulfoxidation and
N-dealkylation.
By the use of various methods for derivative preparations and
GLC, a tentative identification of the N-hydroxymethyl derivative was
made for Zectran and Mesurol.

Also, radioactive area b has been tenta

tively characterized as a 1° amine.

GLC was also used to successfully

identify the main metabolites of Zectran and Mesurol.
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APPENDIX

Spray Reagents
The preparation and proposed mechanism of action, if one is
known, of each functional group spray used in this paper is given
below in alphabetical order.

Also, the traditional functional group

specificity is given.

Bromocresol green.

Certain organic acids could be detected by

a mixture of 0.04 g of bromocresol green with 100 ml of 96 percent
ethanol.

To the reagent was added 0.1 N NaOH until a green color

resulted (Sumere et al., 1965).
Bromophenol blue.

In order to change color from red to blue,

300 mg bromophenol blue dissolved in 500 ml ethanol and 0.25 ml 30
percent NaOH was added.
ground.

Acids should give yellow spots on blue back

The compound also reacted with certain aldehydes and amines

(Reio, 1958).

P-dimethylaminobenaldehyde.

A saturated benzene solution of

p-dimethylaminobenzaldehyde is used.

Primary and secondary amines

condense with p-dimethylaminobenzaldehyde to yield colored Schiff
bases.

RNH„ + OCH
2

3) 2

->

RN=CH

With monamines the Schiff base is yellow.
orange colors are produced (Feigl, 1966).

3)2 + H2°

With di- and polyamines
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Hydroxylamlne.

150 rag hydroxylamine: HCL was dissolved in

14 ml bromophenol blue solution (standard indicator).
adjusted to 7.0 with a few drops of 2 N NaOH.

The pH was

Aromatic aldehydes

reacted rapidly and gave yellow spots on a blue background (Reio, 1958).
This reagent was not helpful.

The control turned a grayish, greenish

blue, benzoic acid turned green, benzaldehyde turned yellow.

This was

not a very specific reagent.

Hydrazine Sulfate.

Should detect aromatic aldehydes.

1 percent hydrazine sulfate solution in IN hydrochloric acid.

Use a
Examine

under UV and check for fluorescence (Saccardi, 1962).
Phloroglucinol.

Phloroglucinol condenses with aryl aldehydes

in concentrated hydrochloric acid to yield orange-pink monomethine
chloride:

1 -tAr—CH

Cl- + h2o

The reagent is prepared by saturating a solution of concentrated HCL
with phloroglucinol.

Usually, it was observed, the result is a faint

outer pink ring with all the compounds spotted (Fiegl, 1966).
P-phenylenediamine.

With aromatic aromatic aldehydes freshly

prepared 1 percent aqueous solutions of p-phenylenediamine should give
yellow to orange colors,

although standards of benzaldehyde gave

grayish-purple colors, while acids turned orange and yellow (Reio,
1958).
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Phosphonolybdic acid.

Two percent aqueous solution somewhat

specific for hydroxyl groups.

It was found that it also reacts with

1° amines, forming a blue color with both (Reio, 1958).
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ABSTRACT

Two critical parameters in the evaluation of the toxicological
hazards of the use of carbamate pesticides are: (1) a rapid, sensitive,
and precise analytical method of identification of the carbamate and
its metabolites; and (2) their metabolism.

A method in this study was

developed whereby various carbamates and their metabolites could be
chromatographed in the gaseous phase.

Also, a comparative in vitro

study of 15,000 g liver supernatants from human, rat, and dog was
performed.

Additional tissues investigated for metabolic activity

toward the carbamates, Zectran and Mesurol, were kidney (from the dog
only) and various blood fractions (red blood cells, serum and whole
blood).

The various homogenates from the liver and kidney were ether-

extracted after incubation.

The ether extract was processed and spotted

on silica gel G thin-layer chromatographic plates and developed bidimensionally to resolve metabolites.
identify the radioactive areas.

Radioautographic analysis was used to
After incubation the blood was treated

in a similar manner as the liver and kidney homogenates.
It was found that, in vitro, the liver was the major site of
metabolism, and that the oxidative enzymes mediated by the NADPH mixed
oxidase system were the major participants in the metabolism of Zectran
and Mesurol.

These enzymes utilized primarily non-hydrolytic pathways

in the processes of degradation.

The main metabolite produced with

Zectran was 4-methylamino-3,5-xylyl N methylcarbamate (MA).

Minor

metabolites produced were 4-dimethylamino-3,5-xylyl N hydroxy methyl
carbamate (NOHME), 4-methylformamido-3,5-xylyl-N methylcarbamate and
4-formamido-3,5-xylyl N methylcarbamate.

The rat and the dog produced
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eight times as much NOHME as the human.

4-methylsulfinyl-3,5-xylyl

N methylcarbamate (sulfoxide) · and 4-methylthio-3,5-xylyl N-methylcarbamate (NOHME) were the major metabolites produced with Mesurol.

The

human and the rat produced four times · as much NOHME as the dog.

These

examples demonstrate the wide interspecies variation prevalent in
Zectran and Mesurol metabolism.
These data indicate that N-dealkylation is the major route of
metabolism for Zectran in all three species.

Minor pathways included

hydroxylation of the carbamate moiety N-methyl groups.

Sulfoxidation

and hydroxylation were the major routes of metabolism with Mesurol in
all three species.
The kidney and blood possessed very low hydrolytic and nonhydrolytic metabolic activity.
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